Inhibition of HSP90 with AUY922 induces synergy in HER2-amplified trastuzumab-resista

['lizbeth]

Paul,

Thanks again for the explanation. I see many targeted therapies that are in early trials. They can't come soon enough for some of our stage IV ladies who could use some more treatment options.

I asked GDP, but I will ask you this too for more insight:

What affect does the supplement L-Tyrosine have on this cancer process?